Literature DB >> 25444365

Primary adnexal angiosarcoma masquerading as periorbital hematoma.

Nicole Lemanski1, Martha Farber2, Bryant P Carruth2, Edward J Wladis2.   

Abstract

We report an elderly woman who was anticoagulated and presented with a recent history of right-sided orbital contusion and a periorbital hematoma without clinical or radiological evidence of focal mass or orbital involvement. She was initially treated conservatively. Continued progression of adnexal swelling and erythema prompted further investigation, however. There was no improvement with surgical drainage alone; biopsy revealed angiosarcoma. The discovery of this vascular tumor underscores the importance of a reconsideration of the diagnosis in the face of counterintuitive findings. Additionally, we emphasize the need to consider malignancy in the differential diagnosis of prolonged periorbital swelling, regardless of a history of recent trauma.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  angiosarcoma; primary adnexal angiosarcoma

Mesh:

Substances:

Year:  2014        PMID: 25444365     DOI: 10.1016/j.survophthal.2014.06.005

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  3 in total

1.  Primary Angiosarcoma of the Skin Presenting as Mild Erythema.

Authors:  Sun Young Moon; Dong Hyuk Eun; Yong Hyun Jang; Seok-Jong Lee; Do Won Kim; Weon Ju Lee
Journal:  Ann Dermatol       Date:  2017-10-30       Impact factor: 1.444

2.  Experience with Orbital Tumors from a Tertiary Cancer Centre of North East India: A Pathology Perspective.

Authors:  Zachariah Chowdhury; Jagannath Dev Sharma; Lopa Mudra Kakoti; Anupam Sarma; Shiraj Ahmed; Munlima Hazarika
Journal:  J Lab Physicians       Date:  2020-11-23

3.  The Eyelid Angiosarcoma: A Systematic Review of Characteristics and Clinical Course.

Authors:  Gyudeok Hwang; Jeongah Shin; Ji-Young Lee; Kyung-Sun Na; Ji-Sun Paik; Hyeon Woo Yim; Suk-Woo Yang; Won-Kyung Cho
Journal:  J Clin Med       Date:  2022-07-20       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.